Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB)

CUSIP: 29405E208

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
1,022,530
Total 13F shares
505,777
Share change
+17,550
Total reported value
$307,294
Price per share
$0.63
Number of holders
17
Value change
-$15,307
Number of buys
9
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 29405E208?
CUSIP 29405E208 identifies ENVB - Enveric Biosciences, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) as of Q2 2024

As of 30 Jun 2024, Enveric Biosciences, Inc. - Common Stock, $0.01 par value (ENVB) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 505,777 shares. The largest 10 holders included AdvisorShares Investments LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, BlackRock Inc., VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, Virtu Financial LLC, Tower Research Capital LLC (TRC), HRT FINANCIAL LP, and OSAIC HOLDINGS, INC.. This page lists 17 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.